Ascentis Independent Advisors
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1845003
DALLAS, TX
Position in REGN
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$367,774
+$93,761 QoQ
Shares Held
476
+34.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ascentis Independent Advisors holds $30,103 across 1 Biotechnology name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
100 | $30,103 |
All Filings in REGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $367,774 | 476 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $274,013 | 355 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $531,907 | 946 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $459,375 | 875 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $917,096 | 1,446 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $967,344 | 1,358 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $90,388 | 86 | Shares | Sole | 2024-10-29 | |
| 2021-06-30 | $311,665 | 558 | Shares | Sole | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||